Thank you, Jan.
a starting take Let's at more second X. financial on our highlights, quarter look Slide detailed
X.X% $XXX million guidance The high an on of were May. representing in second million, back range $X revenues X.X% above quarter approximately on and reported basis. the total a organic basis revenues communicated were Total approximately the end growth
was adjusted to compared Our the EPS down quarter XXXX. XX% $X.XX, for
point change scrap, offset basis P&L, by middle points utilization stronger for remediation higher prior partially and XXX Looking year sales XXX Boston the versus an lower points Skin gross returns gross XX.X% margins mix benefit lower and in were revenue at from approximate margins was The by unfavorable impacted basis from the ] approximately down from Integra [ XXX points and basis of second the versus basis international XXXX. in XXX the costs. quarter, lower
and down compared Our XXX XXXX. to XX% points adjusted EBITDA basis margins were
in margin second reflects the for adjusted gross flow decline Operating Our decrease quarter margins. EBITDA the primarily was cash in million. $XX
up million If reported highlights from DuraGen by dive second revenues a prior in in Mayfield. an for single-digit growth the grew offset on in repair driven on Reported were basis our year. back CFS to franchises, deeper by organic into of revenue basis basis Advanced the Slide quarter. organic turn take saw high X.X% X, XX.X% an with Energy, access CFS single-digit we'll on orders.
We a and driven Global X.X% delivered and sales the you by $XXX growth low Neurosurgery strong in Aurora. impact dural growth and We in certain QX
We Faralink strong also from saw our growth in ] [ neuromonitoring the relaunch franchise.
the double-digit single-digit the effect $XX the we decline growth for following and orders quarter. a midpoint saw reporting $X reflects the our of million, the organic I'd growth synergies a low growth in so, decline X ENT integration to However, the that Even like delivered business, reflect approximately low Acclarent in offset at was quarters in of highlight only CFF will led MicroFrance that ENT [indiscernible] of neuro by the ahead second our for XX% monitoring early segment to a ENT the performance our to back acquisition.
On this the guidance which Acclarent the reflecting date. million instruments first close approximately is of reported the acquisition. basis, management.
In
were For driven our delivering the by in line ] capital second be results for digits, up high monitors, with [ sales which single quarter, our that expectations launch. Ferlink are
the we international an with X% of our in low due saw decline challenging approximate strong international many growth continued We markets. in demand business. instruments. our versus a to quarter single-digit to comp to XXXX.
Shifting saw Turning
in However, in to orders remarks. earlier due back meeting increase quarter the we we fell in short demand discussed the our of
segment our X.X% reported X. Technologies the Tissue on year. prior on an compared basis X.X% to to Moving a Technologies Tissue Slide on organic basis and increased
Excluding Boston, was organic down growth X%.
saw across from focus franchise, DuraSorb, team. growth double-digit the surgical the reconstruction from broad including sales growth sales in wound increased quarter for Second high benefiting reconstruction
double-digit Gentrix challenges We driven also and Cytal we was a reconstruction partially quarter's earnings double-digit last by growth in in decline discussed wound by saw call. mid-double-digit low and production [indiscernible].
Growth Skin the offset Integra during in MicroMatrix, low
fourth at are capacity. of We continued have not over operating expect ramp Skin course we we quarter, production to Skin second normalized While full Integra at still of now sales to Integra the label be the the is the the private from Boston. versus lapping during X.X%, XX% rates sales up approximately recall. quarter.
In up run year, due primarily year label, were to excluding last returns Private prior
Tissue the Boston. due sales up to Technologies international from double lapping were high year digits Finally, returns in prior also
our will you sheet, turn If discuss and structure X, cash I balance to flow. Slide capital
$XX.X During and investments ] from in million, cash MDR spending was free million, cash the [ XX-month was flow quarter, continued working increased was on trailing $XX.X EU primarily and CapEx operating cash on flow XX.X% inventory.
Free reflecting basis. and conversion flow a capital
flexible plans. liquidity a short- and balance support long-term sheet have our to We ample with
total debt was leverage X.Xx net was to billion, target our XX, June of As of consolidated ratio range just $X.X X.Xx and our X.Xx. above
investments total remainder revolving cash in within liquidity $X.X our are target ratio credit facility. company We $XXX and leverage focused billion, the on available our range.
The bringing including our back of million had on and short-term
growth million rates would revolver. through convert rate our flexibility $XXX of to range the X% swap and it with We allow the the investments XXXX. maintain are in liquidity approximately the of due bond Through term take interest the the our our using environment.
With flexibility, that low third balance sheet convertible improvement coming confident rate and to operations current our have strength in will our in even portfolio, XXXX, we long-term fund of end us quarter we to rate interest and all-in fixed strategy debt our execute in
to will and a Our the closely structure. environment along with maintain finance flexible Board, highly our the to treasury work and efficient rate capital continue monitor of committee team,
and will turn consolidated you per our and full XXXX. guidance the to earnings provide If Slide third adjusted I for X, year share revenue quarter
year. we shipping in majority cleared before holes end several As remarks, we of which discussed the a of temporary implemented, the updated have earlier guidance our be will our reflects
by revenues the quarter supply million shipping between Third million, are impact and be temporary back forecasted hold to $XXX $XXX to the orders. driven of
in and of down guidance revenue an to X.X% X.X% on range reported a basis. flat decline updated Our approximately of approximately the represents growth organic X.X% to
the billion the temporary the the levels into range $X.XXX billion as abate of we and be hold to $X.XXX are backorder to in fourth year, to revenues For full quarter. expect forecasted
the of we expect tailwind fourth demand the we shipments While the to slight our a can't able clearance, step-up a in period. only third modest the as many will backorder in substantial meet supply cases in quarter be with quarter providing into lost, revenue are
expect organic X.X% X% full to be be range and for We in growth growth to minus to and reported X.X% XXXX. year X.X% plus the of our the
earnings to per adjusted guidance. share Turning
$X.XX. to expect we $X.XX EPS quarter, third adjusted the be For to
Our resulting third product remediation and from holds. investments the quarter operations lower and EPS scrap due holds the costs higher efforts, utilization in quality, product reflects to plant
full spending year to will to [indiscernible] in can like you to range for our full $X.XX second we EPS increase adjusted that reliably hold The anticipate the through as our the revenue support demand.
I'd be EPS a level considerations well outlook master as to the We year contemplates of half Slide For as network linked deliver we our increased year, full plan. XXXX that to reduction on $X.XX in share. updating we meets key across of this are supply spending per planned invest the and shipping ensure XX. impact temporary to revenue take at XXXX our
As of updated key tax as well rate FX find will count. our you as look the at side average metrics the left share and for page, you
to the and have as to As our and as on ramp drivers guidance OpEx. stepped right third the investments highlights we year we of the side, revenue up well key impact quarter and COGS on fourth quarter look full the
issues, quarter beyond need are lines providing based changes to XXXX meet on we in guidance. we time the to the Based on fourth not some resolve we XXXX. context our our XXXX, appreciate able expected for to XXXX the of Although the guidance should demand identified for be supply
also disruption master expect XXXX, execute which for we mid-single-digit into compliance organic to products, we XXXX, demand our over the strong growth pockets supply but as plan. see takes For account revenue of
flat of all this We make see margins EPS XXXX. growth into investments. on we account, as adjusted to adjusted modest pressure gross our also expect we Taking to in key expect to continue
an master continued strong reflected commercial remain our during committed our providing I'll order to our over our in our improve support quality Acclarent plan. saw our ] teams our like and XX, forward I'd supply manufacturing turn We do can products remarks. the organization-wide to sustainable make commitment through growth line the and quarter, we compliance second required for prepared to that progress customers and Slide that, we have meet needs. our Q&A. network to our up time.
In advancing demand with their generate and better in and up that, remain [ to confident our wrap we investment for including are updates across look We portfolio compliance SurgumMPMA you resilience new bring and to Braintree With as updated IBDR.
The to back and ] we PriMatrix guidance facility you to [ for SurgiMend open against market If
As Please facilitate present line open question. Jan the Q&A. will is for Stuart not [ the physically call, first the ] for I and the